Vania Nose, MD, PhD
Vania Nose, MD, PhD
Director, Surgical Pathology
About Vania Nose, MD, PhD
Dr. Nose is a surgical pathologist with subspecialty expertise in endocrine pathology. She has served as a consultant for difficult endocrine pathology cases locally, regionally, and internationally. Dr. Nose has published extensively on endocrine pathology, tumor pathology, and also in molecular aspects of neoplasia with over 150 peer-reviewed articles. Dr. Nose has described the pathological classification of familial thyroid tumors, inherited tumor syndromes, as well as the pituitary pathology synoptic reporting. She is the author of the CAP endocrine pathology competencies. She had served on the editorial boards of numerous pathology journals and is a past President of the Endocrine Pathology Society. Dr. Nose authored a comprehensive textbook in endocrine pathology titled "Diagnostic Pathology: Endocrine."
Clinical Interests:
- Thyroid pathology
- Thyroid tumors
- Adrenal tumors
- Pituitary tumors
- Parathyroid tumors
- Endocrine pathology
- Endocrine tumors
- Surgical pathology
- Salivary gland tumors
- Endocrine pancreas
Treats:
- Adult & Pediatrics
Languages:
- Portuguese
Locations
Pathology Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-643-7201
Medical Education
- PhD, Federal University of Sao Paulo
- MD, State University of Campinas School of Medical Sciences
- Residency, Boston Children's Hospital
- Residency, Boston Medical Center
- Residency, Boston University Hospital
- Residency, Children's Hospital Boston
- Residency, Mallory Institute, Boston City Hospital
- Residency, New England Deaconess Hospital
- Residency, Rhode Island Hospital
- Residency, Rhode Island Hospital/Lifespan
American Board Certifications
- Clinical Pathology, American Board of Pathology
- Anatomic Pathology, American Board of Pathology
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- MassHealth
- Medicare
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
View my most recent publications at PubMed
Son E, Nose V. Familial follicular cell-derived thyroid carcinoma.Front Endocrinol (Lausanne). 2012;3:61
Nose V, et al. Protocol for the examination of specimens from patients with primary pituitary tumors. Arch Pathol Lab Med.2011;135(5):640-6
Nose V. Familial thyroid cancer: a review. Mod Pathol.2011;24 S2:S19-33
Chen J, Faquin W, Lloyd R, Nose V. Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma.Mod Pathol.2011;24(5):739-49
Laury A, et al, Nose V. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. Thyroid. 2011;21(2):135-44
Nose V. Thyroid cancer of follicular cell origin in inherited tumor syndromes. Adv Anat Pathol. 2010;17(6):428-36
Sadow P,et al, Nose V. Absence of BRAF,NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas. EndocrPathol.2010;21(2):73-9
Nose V. Familial follicular cell tumors:classification and morphological characteristics. EndocrPathol.2010;21(4):219-26
Schmidt J, et al, Nose V. BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am J Surg Pathol. 2007;31(9):1337-43
Reimann J, Dorfman D, Nose V. Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol. 2006;30(8):994-1001